SCHEMBL4756594

SCHEMBL4756594

Cc1coc(S(=O)(=O)c2cnc(NC(=O)c3cccc(Cl)c3O)s2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
MAPT P10636 3/20 0.45
CRHBP P24387 2/20 0.45
CRHR2 Q13324 2/20 0.45
STAT3 P40763 1/20 0.44
GRM4 Q14833 4/20 0.42
KDR P35968 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 1/20 0.41
PDE10A Q9Y233 1/20 0.41
LCK P06239 3/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
STIM1 Q13586 1/20 0.37
ORAI1 Q96D31 1/20 0.37
MAPK13 O15264 1/20 0.37
EGFR P00533 1/20 0.37
FYN P06241 1/20 0.37
HCK P08631 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13524032 0.71 CCNE1 (0.50) MEN1KMT2ASTAT3KDRSMN1; SMN2
SCHEMBL4755798 0.71 STAT3 (0.63) MEN1KMT2AMAPTCRHBPCRHR2
SCHEMBL4756596 0.70 CRHBP (0.66) MEN1KMT2AMAPTCRHBPCRHR2
SCHEMBL4756965 0.68 FFAR2 (0.48) MEN1KMT2AMAPTCRHBPCRHR2
SCHEMBL4756542 0.68 STAT3 (0.47) MEN1KMT2AMAPTCRHBPCRHR2
SCHEMBL4757405 0.68 MEN1 (0.46) MEN1KMT2AMAPTSTAT3GRM4
SCHEMBL10114188 0.67 RAB9A (0.51) MEN1KMT2AMAPTGRM4KDR
SCHEMBL4755842 0.67 STAT3 (0.47) MEN1KMT2AMAPTCRHBPCRHR2
SCHEMBL23026966 0.67 STAT3 (0.67) STAT3KDRSMN1; SMN2LCKALDH1A1
SCHEMBL4756651 0.67 GRM4 (0.49) MEN1KMT2AMAPTCRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
WO-2009035788-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. (US) 2009-03-19 WO disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MEN1 4564/4885KMT2A 2303/4885MAPT 4288/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MEN1 4564/4885KMT2A 2303/4885MAPT 4288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.